Junfeng Zhang

1.1k total citations
50 papers, 774 citations indexed

About

Junfeng Zhang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Junfeng Zhang has authored 50 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 20 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Junfeng Zhang's work include Pancreatic and Hepatic Oncology Research (22 papers), Pancreatitis Pathology and Treatment (6 papers) and Cancer Genomics and Diagnostics (5 papers). Junfeng Zhang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (22 papers), Pancreatitis Pathology and Treatment (6 papers) and Cancer Genomics and Diagnostics (5 papers). Junfeng Zhang collaborates with scholars based in China, United States and Portugal. Junfeng Zhang's co-authors include Yan‐Miao Huo, Jianhui Zhu, Rong Hua, Yongmei Zhao, Weijiang He, Zijian Guo, Jian‐Yu Yang, Yongwei Sun, Minwei Yang and Yangguang Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Junfeng Zhang

45 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfeng Zhang China 16 414 338 120 101 100 50 774
Lihui Wei United States 16 365 0.9× 304 0.9× 47 0.4× 155 1.5× 157 1.6× 37 1.2k
Michael C. Burns United States 15 239 0.6× 752 2.2× 52 0.4× 103 1.0× 53 0.5× 23 1.1k
Rajesh Manne India 16 242 0.6× 349 1.0× 112 0.9× 140 1.4× 35 0.3× 29 755
Xiaohui Zheng China 20 192 0.5× 712 2.1× 125 1.0× 101 1.0× 211 2.1× 65 1.5k
Lihua Du China 16 237 0.6× 514 1.5× 136 1.1× 86 0.9× 176 1.8× 28 1.1k
Mackenzie K. Herroon United States 17 506 1.2× 360 1.1× 288 2.4× 196 1.9× 214 2.1× 26 1.2k
Bo Yuan China 18 209 0.5× 443 1.3× 311 2.6× 103 1.0× 169 1.7× 43 1.1k
Carsten Höltke Germany 19 340 0.8× 346 1.0× 310 2.6× 104 1.0× 92 0.9× 53 1.1k
Kumaresan Ganesan India 16 239 0.6× 574 1.7× 224 1.9× 61 0.6× 132 1.3× 45 967
Carmen A. Widmer Switzerland 3 320 0.8× 318 0.9× 75 0.6× 127 1.3× 71 0.7× 3 698

Countries citing papers authored by Junfeng Zhang

Since Specialization
Citations

This map shows the geographic impact of Junfeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Zhang more than expected).

Fields of papers citing papers by Junfeng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Zhang. The network helps show where Junfeng Zhang may publish in the future.

Co-authorship network of co-authors of Junfeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Zhang. A scholar is included among the top collaborators of Junfeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Zhang. Junfeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Dong, et al.. (2025). Lifespan‐Regulated CAR‐Macrophages from Myeloid Progenitors for Enhanced Colorectal Cancer Therapy. Advanced Science. 12(43). e17677–e17677.
2.
Yu, Xiaolong, Zhiping Zhou, Xiaohan Li, et al.. (2025). Gamma-caprolactone-based isolation of Pseudomonas sp. YH-1: A novel quorum quenching bacterium for AHL degradation and biofouling control. Chemical Engineering Journal. 520. 166280–166280.
4.
Hu, Jingchao, Zhuo Yang, Min Wang, et al.. (2025). Effect of GLP-1RA on coronary progression and cardiovascular outcomes in type 2 diabetic patients after PCI: a prospective cohort study. Scientific Reports. 15(1). 31824–31824. 1 indexed citations
5.
Zou, Libin, Yang Yu, Yongqiang Liu, et al.. (2024). The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression. SHILAP Revista de lepidopterología. 5(12). e70026–e70026. 14 indexed citations
6.
Yao, Hong‐Fei, Min He, Bo Zhang, et al.. (2023). Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature. Heliyon. 10(1). e22774–e22774. 3 indexed citations
7.
Yao, Hong‐Fei, Dapeng Xu, Yu Xu, et al.. (2023). Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer. APOPTOSIS. 28(7-8). 1090–1112. 15 indexed citations
8.
Zhang, Junfeng, Jiali Yang, Qiang Zhou, et al.. (2023). The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance. Drug Resistance Updates. 73. 101027–101027. 5 indexed citations
9.
Zhang, Junfeng, et al.. (2023). The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer. Frontiers in Immunology. 14. 1166128–1166128. 15 indexed citations
10.
11.
Huo, Yan‐Miao, Jian Yang, Dapeng Xu, et al.. (2022). Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL‐6 trans‐signalling. Cell Proliferation. 55(5). e13237–e13237. 9 indexed citations
13.
Yang, Jian‐Yu, Yu Xu, Yan‐Miao Huo, et al.. (2021). ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer. Journal of Immunology Research. 2021. 1–10. 8 indexed citations
14.
Zhang, Junfeng, Hui Sun, Songsong Liu, et al.. (2020). Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Aging. 12(22). 23217–23232. 16 indexed citations
15.
Liu, Songsong, Lang Gan, Tao Peng, et al.. (2020). Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation. Genomics. 112(6). 5343–5355. 18 indexed citations
16.
Yang, Jian‐Yu, Yongsheng Jiang, Ruizhe He, et al.. (2019). DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Journal of Immunology Research. 2019. 1–12. 9 indexed citations
17.
Yang, Jian‐Yu, Junfeng Zhang, Yan‐Miao Huo, et al.. (2019). Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection. HPB. 22(1). 91–101. 31 indexed citations
18.
Shen, Chaoqin, Tingting Yan, Wei Liu, et al.. (2017). High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation. Journal of Cancer. 8(16). 3154–3165. 25 indexed citations
19.
Zhang, Junfeng, Yongwei Sun, Wei Liu, et al.. (2015). Pseudomonas aeruginosa Infection after Pancreatoduodenectomy: Risk Factors and Clinic Impacts. Surgical Infections. 16(6). 769–774. 13 indexed citations
20.
Zhao, Yongmei, Jianhui Zhu, Weijiang He, et al.. (2006). Oxidative DNA Cleavage Promoted by Multinuclear Copper Complexes: Activity Dependence on the Complex Structure. Chemistry - A European Journal. 12(25). 6621–6629. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026